Smith & Nephew acquires Extremity Orthopedics business of Integra LifeSciences Holdings Corporation for $240 million
Client(s) Smith & Nephew plc
Jones Day advised Smith & Nephew plc, the global medical technology company, in its acquisition of the Extremity Orthopedics business of Integra LifeSciences Holdings Corporation (NASDAQ: IART) for $240 million on a cash and debt-free basis. The transaction included the sale of Integra’s upper and lower extremity orthopedics product portfolio, including ankle and shoulder arthroplasty and hand and wrist product lines.